| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| PCAT1 |
|
prostate cancer associated transcript 1
|
|
|
0.575 |
0.615 |
| MIR3681HG |
|
MIR3681 host gene
|
|
|
0.736 |
0.269 |
| LINC01185 |
|
long intergenic non-protein coding RNA 1185
|
|
|
0.743 |
0.346 |
| IL12A-AS1 |
|
IL12A antisense RNA 1
|
|
|
0.633 |
0.654 |
| CASC19 |
|
cancer susceptibility 19
|
|
|
0.769 |
0.423 |
| LINC01147 |
|
long intergenic non-protein coding RNA 1147
|
|
|
0.821 |
0.192 |
| MIR181A1HG |
|
MIR181A1 host gene
|
|
|
0.861 |
0.115 |
| WTAPP1 |
|
Wilms tumor 1 associated protein pseudogene 1
|
|
|
0.890 |
0.154 |
| LINC02580 |
|
long intergenic non-protein coding RNA 2580
|
|
|
0.931 |
0.192 |
| CHROMR |
|
cholesterol induced regulator of metabolism RNA
|
|
|
0.861 |
0.154 |
| LINC01967 |
|
long intergenic non-protein coding RNA 1967
|
|
|
0.931 |
0.115 |
| IGHA1 |
P01876
|
immunoglobulin heavy constant alpha 1
|
|
|
0.617 |
0.692 |
| HLA-F-AS1 |
|
HLA-F antisense RNA 1
|
|
|
0.861 |
0.269 |
| HLA-DRB6 |
|
major histocompatibility complex, class II, DR beta 6 (pseudogene)
|
|
|
0.821 |
0.308 |
| ZNF767P |
Q75MW2
|
zinc finger family member 767, pseudogene
|
|
|
1.000 |
0.077 |
| HNRNPA1P68 |
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 68
|
|
|
1.000 |
0.077 |
| PKIA-AS1 |
|
PKIA antisense RNA 1
|
|
|
1.000 |
0.077 |
| ZNF433-AS1 |
|
ZNF433 and ZNF878 antisense RNA 1
|
|
|
1.000 |
0.077 |
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
| TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |
| ARHGEF10 |
O15013
|
Rho guanine nucleotide exchange factor 10
|
Enzyme
|
6.8E-30 |
0.729 |
0.577 |
| AHI1 |
Q8N157
|
Abelson helper integration site 1
|
|
1.1E-25 |
0.513 |
0.846 |
| SPEF2 |
Q9C093
|
sperm flagellar 2
|
|
3.1E-25 |
0.792 |
0.269 |